BY RALPH BLUM
A recent UCLA
study found that a significant percentage of men diagnosed with low-risk
prostate cancer who chose "active surveillance," rather than
aggressive treatment in order to avoid the debilitating side effects of surgery
or radiation, don't follow up with the required tests and office visits.
This is
an alarming finding, because not being monitored appropriately puts them in
danger of the cancer progressing or metastasizing without their knowledge.
Before patients decide on active surveillance as a management option for
prostate cancer they should agree with their physician on a strict follow-up
schedule to closely monitor the cancer.
There is
no doubt in my mind that active surveillance is the smart treatment option for
low-risk prostate cancer. With other cancers, or if the prostate
cancer is aggressive, the main issue is survival. But with low-risk prostate
cancer, since long survival is the norm, the most important consideration
is quality of life. Having said that, with active surveillance regular
check-ups are essential, because when men are watched closely, treatment can be
started at the first sign of cancer progression.
So what
does active surveillance require? How exactly is it carried out?
Different
centers have different requirements. At a 2007 Active Surveillance Conference,
attended by over 200 of the world's leading prostate cancer experts, the
attendees recommended a biopsy after one year, subsequently repeating it every
two to three years. But as I have often said, I am not a fan of biopsies. So I
prefer to recommend doing a repeat targeted biopsy only on the basis of a PSA and
prostate imaging with either color Doppler ultrasound or 3T multi-parametric MRI.
Here is
an Active Surveillance Protocol that Dr. Mark Scholz recommends:
PSA every three months
Rectal examination every 12 months
Color Doppler ultrasound annually
Multi-parametric MRI annually
Whatever
protocol your urologist recommends you need to be committed to following it. It
may be inconvenient or uncomfortable but the alternative is aggressive
treatment that has the potential to leave you with erectile and urinary
dysfunction.
There is
always the consideration to just treat the cancer and be rid of it. But having
lived with this disease for over two decades, with my prostate intact, I am a
firm believer in avoiding radical treatment and preserving quality of life as
long as possible. And if you have low-risk prostate cancer, bear in mind
that the longer you can wait before you submit to radical treatment, the better
the odds are that research in the field will have advanced, and treatment will
have become more effective and less
toxic.
No comments:
Post a Comment